Understanding HIV latency and how to stop it is the key to finding a cure. People infected with HIV must follow a strict regimen of drug treatment to prevent the disease from progressing into AIDS. Treatment, however, does not cure HIV; it merely subdues the virus. If the patient stops treatment, the virus “wakes up” […]
Could we see the end of HIV/AIDS epidemic in our lifetime? Researchers are getting closer to a possible cure. Truvada, a drug that has long been used as treatment for HIV-positive patients, is also the first and only FDA-approved medication to prevent HIV. Researcher Robert Grant of the UCSF-affiliated Gladstone Institutes conducted a study that […]
Diane Havlir is a professor of medicine at the University of California, San Francisco (UCSF) and the chief of the UCSF Division of HIV/AIDS and Positive Health Program at San Francisco General Hospital and Trauma Center. She served as co-chair of AIDS 2012, the XIX international AIDS Conference.
The scourges of immune-compromised HIV patients have always included opportunistic, chronic infection with other viruses — among them the herpes viruses that cause Kaposi’s sarcoma and chronic cytomegalovirus (CMV) infection. Before antiretroviral therapy became effective and widely available in the United States, Kaposi’s sarcoma — a form of cancer — was common and sometimes a […]
UCSF’s Steven Deeks, MD, professor of medicine at the UCSF Division of HIV/AIDS at San Francisco General Hospital and Trauma Center and Trauma Center, spoke on NPR’s “Talk of the Nation” on July 24, 2012 with host Neal Conan, discussing working toward a cure for HIV/AIDS.
This is a snippet from an interview with Steve Morin in which he discusses what is behind the bipartisan support of PEPFAR, the U.S. President’s Emergency Plan for AIDS Relief. “PEPFAR enjoys strong bipartisan support for a number of reasons,” Morin said. “It responds to a humanitarian need, it is vital to some of our […]
This is a snippet from an interview with Paul Volberding in which he discusses the successes, challenges and the future of PEPFAR, the U.S. President’s Emergency Plan for AIDS Relief. “PEPFAR has been an enormously important project of the U.S. government, “Started under George Bush, it has been the vehicle by which the U.S government […]
It is unclear which of the treatments that the “Berlin Patient” received were necessary and/or sufficient for what appears to be at minimum a clinical cure.
Timothy Henrich et al presented intriguing data from two HIV-infected patients who received reduced-intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (HSCT) for the treatment of relapsed Hodgkin’s lymphoma.